VERISANTE TECHNOLOGY Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VERISANTE TECHNOLOGY

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: andre dallaire	11/1/2012 1:57:53 PM
	of 254

Verisante in Chatelaine magazine: Verisante Aura Featured on CTV, Global and Chatelaine Magazine November 1, 2012 After placing Verisante Aura units for testing in Calgary and Edmonton, Global TV in Calgary and CTV News in Edmonton recently did features on the clinics hosting the devices. View Dr. Lycka speaking on the device in Edmonton here: http://edmonton.ctvnews.ca/video?playlistId=1.1011300 And Dr. Metelitsa speaking on the device in Calgary here: http://www.globaltvcalgary.com/video/index.html?v=QYb0uDzWH6LyIQgcA8vfD0XLgIelmaa4#health+fyi Finally, check out page 180 of the current November issue of Chatelaine Magazine - Aura is mentioned in their Future of Medicine feature! About Verisante Technology, Inc. Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer. The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and tested and refined at the Skin Care Centre at Vancouver General Hospital. This exclusive platform technology allows Verisante to develop and offer a range of compact, non-invasive cancer detection devices that offer physicians immediate results for many of the most common cancers. The Aura™ has been approved for sale in Canada, Europe and Australia. The Core™ has not yet been approved for sale. Verisante Aura™ was recently awarded Popular Science Magazine’s “Best of What’s New Award” for 2011, and Verisante Core™ was named one of the top 10 cancer breakthroughs of 2011 by the Canadian Cancer Society. In addition, the Company was named a finalist for the 2011 Regional Awards for New Technology by the Canadian Manufacturers & Exporters and the National Research Council of Canada and named as the year’s top ranking Technology and Life Sciences Company on the TSX Venture 50. Contact Verisante Technology, Inc. Thomas Braun, President & CEO Telephone: (604) 605-0507 Email: info@verisante.com Website: www.verisante.com Youtube: www.youtube.com/verisante Twitter: www.twitter.com/verisante Facebook: www.facebook.com/verisante Read more at http://www.stockhouse.com/bullboards/messagedetail.aspx?p=0&m=31726428&l=0&r=0&s=VRS&t=LIST#uGrTIasG0BX3eTTz.99

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next